(1) - Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system and the prevention and treatment of autoimmune and inflammatory diseases
(2) - Education and providing of training in relation to the prevention and treatment of disorders of the nervous system and the prevention and treatment of autoimmune and inflammatory diseases
(3) - Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, namely, multiple sclerosis, Alzheimer's, Huntington's disease, cerebral palsy, mood disorders, anxiety disorders, cognitive disorders and schizophrenia; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases; and anti-inflammatory medications.
(4) - Education, namely, educational research services and the provision of training, both of which are in relation to the prevention and treatment of disorders of the nervous system and the prevention and treatment of autoimmune and inflammatory diseases
(5) - Medical diagnostic services, medical research services, and medical laboratory services for the prevention and treatment of disorders of the nervous system and the prevention and treatment of autoimmune and inflammatory diseases.
(6) - Medical services in relation to the prevention and treatment of disorders of the nervous system and the prevention and treatment of autoimmune and inflammatory diseases
|